NECFA
AVNS

New England Capital Financial Advisors’s Avanos Medical AVNS Stock Holding History

New England Capital Financial Advisors’s Portfolio AVNS Stock Details AVNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$150 Hold
6
– – ﹤0.01% 418
2026
Q1 		$85 Hold
6
– – ﹤0.01% 414
2025
Q4 		$68 Hold
6
– – ﹤0.01% 412
2025
Q3 		$70 Hold
6
– – ﹤0.01% 413
2025
Q2 		$74 Hold
6
– – ﹤0.01% 414
2025
Q1 		$86 Hold
6
– – ﹤0.01% 382
2024
Q4 		$96 Hold
6
– – ﹤0.01% 402
2024
Q3 		$145 Hold
6
– – ﹤0.01% 383
2024
Q2 		$120 Hold
6
– – ﹤0.01% 383
2024
Q1 		$120 Hold
6
– – ﹤0.01% 386
2023
Q4 		$135 Sell
6
-3
-33% -$62 ﹤0.01% 388
2023
Q3 		$182 Hold
9
– – ﹤0.01% 376
2023
Q2 		$231 Hold
9
– – ﹤0.01% 370
2023
Q1 		$268 Hold
9
– – ﹤0.01% 409
2022
Q4 		$265 Buy
+9
New +$220 ﹤0.01% 412

Other funds holding AVNS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
SRC
Samson Rock Capital London, United Kingdom $45.6M AUM 86.17% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.6B AUM 93.19% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
CIEC
Crédit Industriel et Commercial Paris France, France $1.55B AUM 42.08% 1-Year Est. Return
TMAM
Tokio Marine Asset Management Tokyo, Japan $3.23B AUM 37.2% 1-Year Est. Return
KIM
Kestrel Investment Management San Mateo, California $184M AUM 31.66% 1-Year Est. Return
FIA
FNY Investment Advisers New York $278M AUM 98.99% 1-Year Est. Return

New England Capital Financial Advisors's AVNS Position: Q2 2026 in Review

New England Capital Financial Advisors held its Avanos Medical (AVNS) position steady in Q2 2026 at 6 shares worth $150. The position accounts for ﹤0.01% of the portfolio, ranked #418.

New England Capital Financial Advisors first reported a position in AVNS in Q4 2022 and has held it in 15 quarters since. The position peaked at $268 in Q1 2023. 128 funds tracked by Wall St. Rank hold AVNS as of Q2 2026.

  • New England Capital Financial Advisors held 6 shares of Avanos Medical worth $150 as of Q2 2026.
  • New England Capital Financial Advisors left its Avanos Medical share count unchanged in Q2 2026.
  • Avanos Medical made up ﹤0.01% of New England Capital Financial Advisors's portfolio in Q2 2026, its #418 holding.
  • New England Capital Financial Advisors first reported a position in Avanos Medical in Q4 2022 and has held it in 15 quarters since.
  • New England Capital Financial Advisors's Avanos Medical position peaked at $268 in Q1 2023.
  • 128 funds tracked by Wall St. Rank held Avanos Medical as of Q2 2026.

Based on New England Capital Financial Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.